CME

CME GROUP INC. CME

NasdaqLarge CapFinancials

13F Pro quality score

Rank #332 of 2,925TOP 25%

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$1.74B

Quarter to Sep 30

Net income

$1.04B

Quarter to Sep 30

Free cash flow

$1.07B

Quarter to Sep 30

Operating margin

65.7%

Quarter to Sep 30

Top Institutional Holders

as of Q2 2026
$71.11B total

What's Driving CME's Business? Latest 10-Q Breakdown

23/23 datapoints verified

AI-extracted from the 10-Q filed 2026-10-23 — Q3 FY2026 (quarter ended September 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

CME Group's third-quarter total revenues rose 13% to $1,737.3M, driven by a 12% increase in clearing and transaction fees and 20% growth in market data and information services.

Biggest Revenue Drivers

Clearing and transaction fees$1,378.1M+12% YoY

Net increases of $141.8M from change in total contract volume ($179.1M), partially offset by decreases from lower average rate per contract ($37.3M).

Market data and information services$243.1M+20% YoY

Largely due to higher usage of certain products, increased demand by new customer segments, and price increases for certain products.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Key Metrics

Revenue

Q3 2026
EDGAR

Net Income

Q3 2026
EDGAR

EPS (Diluted)

Q3 2026
EDGAR

Operating Margin

Q3 2026
EDGAR

ROIC

Q3 2026
EDGAR

Free Cash Flow

Q3 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CME

Earnings Per Share

13fpro.ai/company/CME

Loading ratio trend…

CME key financials by period

Reported revenue, net income and operating margin by fiscal year, from CME GROUP INC.'s annual filings on SEC EDGAR.

CME GROUP INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$6.5B$4.1B64.9%
FY 2024$6.1B$3.5B64.1%
FY 2023$5.6B$3.2B61.6%
FY 2022$5.0B$2.7B60.1%
FY 2021$4.7B$2.6B56.4%
FY 2020$4.9B$2.1B54.0%
Source: CME filings on SEC EDGAR →

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

CME insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in CME

31 transactions in CME reported by 16 members of Congress under the STOCK Act, most recent trade Jun 16, 2026. Reported transactions, not recommendations.

All Congress stock trades →

About CME GROUP INC. (CME): stock profile, AI score and financials

CME GROUP INC. (CME) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. 13F Pro's AI-powered ranking engine scores CME at 67.9/100 on a composite quality score built from its SEC filings, placing it at rank #332 of 2,925 stocks — the top 25% of the AI-ranked universe. CME scores in the top quartile across profitability (98.3), free cash flow (97.1), revenue scale (82.6). Areas of concern include earnings quality (39.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q3 2026), CME GROUP INC. reports quarterly revenue of $1.7B, net income of $1.0B, an operating margin of 65.7%. Top institutional holders of CME by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CME trades on the Nasdaq exchange and files with the SEC under CIK 1156375. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CME daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CME GROUP INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1156375 →